- IBDEI12R ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,17462,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17462,1,3,0)
- ;;=3^Clubbing of Fingers
- ;;^UTILITY(U,$J,358.3,17462,1,4,0)
- ;;=4^R68.3
- ;;^UTILITY(U,$J,358.3,17462,2)
- ;;=^5019553
- ;;^UTILITY(U,$J,358.3,17463,0)
- ;;=R73.01^^61^787^93
- ;;^UTILITY(U,$J,358.3,17463,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17463,1,3,0)
- ;;=3^Impaired Fasting Glucose
- ;;^UTILITY(U,$J,358.3,17463,1,4,0)
- ;;=4^R73.01
- ;;^UTILITY(U,$J,358.3,17463,2)
- ;;=^5019561
- ;;^UTILITY(U,$J,358.3,17464,0)
- ;;=R73.02^^61^787^94
- ;;^UTILITY(U,$J,358.3,17464,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17464,1,3,0)
- ;;=3^Impaired Glucose Tolerance (oral)
- ;;^UTILITY(U,$J,358.3,17464,1,4,0)
- ;;=4^R73.02
- ;;^UTILITY(U,$J,358.3,17464,2)
- ;;=^5019562
- ;;^UTILITY(U,$J,358.3,17465,0)
- ;;=R73.09^^61^787^18
- ;;^UTILITY(U,$J,358.3,17465,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17465,1,3,0)
- ;;=3^Abnormal Glucose NEC
- ;;^UTILITY(U,$J,358.3,17465,1,4,0)
- ;;=4^R73.09
- ;;^UTILITY(U,$J,358.3,17465,2)
- ;;=^5019563
- ;;^UTILITY(U,$J,358.3,17466,0)
- ;;=R73.9^^61^787^88
- ;;^UTILITY(U,$J,358.3,17466,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17466,1,3,0)
- ;;=3^Hyperglycemia,Unspec
- ;;^UTILITY(U,$J,358.3,17466,1,4,0)
- ;;=4^R73.9
- ;;^UTILITY(U,$J,358.3,17466,2)
- ;;=^5019564
- ;;^UTILITY(U,$J,358.3,17467,0)
- ;;=R76.11^^61^787^146
- ;;^UTILITY(U,$J,358.3,17467,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17467,1,3,0)
- ;;=3^Positive PPD
- ;;^UTILITY(U,$J,358.3,17467,1,4,0)
- ;;=4^R76.11
- ;;^UTILITY(U,$J,358.3,17467,2)
- ;;=^5019570
- ;;^UTILITY(U,$J,358.3,17468,0)
- ;;=R79.1^^61^787^3
- ;;^UTILITY(U,$J,358.3,17468,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17468,1,3,0)
- ;;=3^Abnormal Coagulation Profile
- ;;^UTILITY(U,$J,358.3,17468,1,4,0)
- ;;=4^R79.1
- ;;^UTILITY(U,$J,358.3,17468,2)
- ;;=^5019591
- ;;^UTILITY(U,$J,358.3,17469,0)
- ;;=R82.5^^61^787^73
- ;;^UTILITY(U,$J,358.3,17469,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17469,1,3,0)
- ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
- ;;^UTILITY(U,$J,358.3,17469,1,4,0)
- ;;=4^R82.5
- ;;^UTILITY(U,$J,358.3,17469,2)
- ;;=^5019605
- ;;^UTILITY(U,$J,358.3,17470,0)
- ;;=R82.6^^61^787^29
- ;;^UTILITY(U,$J,358.3,17470,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17470,1,3,0)
- ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
- ;;^UTILITY(U,$J,358.3,17470,1,4,0)
- ;;=4^R82.6
- ;;^UTILITY(U,$J,358.3,17470,2)
- ;;=^5019606
- ;;^UTILITY(U,$J,358.3,17471,0)
- ;;=R82.90^^61^787^28
- ;;^UTILITY(U,$J,358.3,17471,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17471,1,3,0)
- ;;=3^Abnormal Urine Findings,Unspec
- ;;^UTILITY(U,$J,358.3,17471,1,4,0)
- ;;=4^R82.90
- ;;^UTILITY(U,$J,358.3,17471,2)
- ;;=^5019609
- ;;^UTILITY(U,$J,358.3,17472,0)
- ;;=R82.91^^61^787^52
- ;;^UTILITY(U,$J,358.3,17472,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17472,1,3,0)
- ;;=3^Chromoabnormalities of Urine NEC
- ;;^UTILITY(U,$J,358.3,17472,1,4,0)
- ;;=4^R82.91
- ;;^UTILITY(U,$J,358.3,17472,2)
- ;;=^5019610
- ;;^UTILITY(U,$J,358.3,17473,0)
- ;;=R89.9^^61^787^22
- ;;^UTILITY(U,$J,358.3,17473,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17473,1,3,0)
- ;;=3^Abnormal Organ/Tissue Specimen Findings,Unspec
- ;;^UTILITY(U,$J,358.3,17473,1,4,0)
- ;;=4^R89.9
- ;;^UTILITY(U,$J,358.3,17473,2)
- ;;=^5019702
- ;;^UTILITY(U,$J,358.3,17474,0)
- ;;=R90.0^^61^787^102
- ;;^UTILITY(U,$J,358.3,17474,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,17474,1,3,0)
- ;;=3^Intracranial Space-Occupying Lesion Dx Imaging of Central Nervous System
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI12R 3808 printed Feb 18, 2025@23:26:59 Page 2
- IBDEI12R ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,17462,1,0)
- +2 ;;=^358.31IA^4^2
- +3 ;;^UTILITY(U,$J,358.3,17462,1,3,0)
- +4 ;;=3^Clubbing of Fingers
- +5 ;;^UTILITY(U,$J,358.3,17462,1,4,0)
- +6 ;;=4^R68.3
- +7 ;;^UTILITY(U,$J,358.3,17462,2)
- +8 ;;=^5019553
- +9 ;;^UTILITY(U,$J,358.3,17463,0)
- +10 ;;=R73.01^^61^787^93
- +11 ;;^UTILITY(U,$J,358.3,17463,1,0)
- +12 ;;=^358.31IA^4^2
- +13 ;;^UTILITY(U,$J,358.3,17463,1,3,0)
- +14 ;;=3^Impaired Fasting Glucose
- +15 ;;^UTILITY(U,$J,358.3,17463,1,4,0)
- +16 ;;=4^R73.01
- +17 ;;^UTILITY(U,$J,358.3,17463,2)
- +18 ;;=^5019561
- +19 ;;^UTILITY(U,$J,358.3,17464,0)
- +20 ;;=R73.02^^61^787^94
- +21 ;;^UTILITY(U,$J,358.3,17464,1,0)
- +22 ;;=^358.31IA^4^2
- +23 ;;^UTILITY(U,$J,358.3,17464,1,3,0)
- +24 ;;=3^Impaired Glucose Tolerance (oral)
- +25 ;;^UTILITY(U,$J,358.3,17464,1,4,0)
- +26 ;;=4^R73.02
- +27 ;;^UTILITY(U,$J,358.3,17464,2)
- +28 ;;=^5019562
- +29 ;;^UTILITY(U,$J,358.3,17465,0)
- +30 ;;=R73.09^^61^787^18
- +31 ;;^UTILITY(U,$J,358.3,17465,1,0)
- +32 ;;=^358.31IA^4^2
- +33 ;;^UTILITY(U,$J,358.3,17465,1,3,0)
- +34 ;;=3^Abnormal Glucose NEC
- +35 ;;^UTILITY(U,$J,358.3,17465,1,4,0)
- +36 ;;=4^R73.09
- +37 ;;^UTILITY(U,$J,358.3,17465,2)
- +38 ;;=^5019563
- +39 ;;^UTILITY(U,$J,358.3,17466,0)
- +40 ;;=R73.9^^61^787^88
- +41 ;;^UTILITY(U,$J,358.3,17466,1,0)
- +42 ;;=^358.31IA^4^2
- +43 ;;^UTILITY(U,$J,358.3,17466,1,3,0)
- +44 ;;=3^Hyperglycemia,Unspec
- +45 ;;^UTILITY(U,$J,358.3,17466,1,4,0)
- +46 ;;=4^R73.9
- +47 ;;^UTILITY(U,$J,358.3,17466,2)
- +48 ;;=^5019564
- +49 ;;^UTILITY(U,$J,358.3,17467,0)
- +50 ;;=R76.11^^61^787^146
- +51 ;;^UTILITY(U,$J,358.3,17467,1,0)
- +52 ;;=^358.31IA^4^2
- +53 ;;^UTILITY(U,$J,358.3,17467,1,3,0)
- +54 ;;=3^Positive PPD
- +55 ;;^UTILITY(U,$J,358.3,17467,1,4,0)
- +56 ;;=4^R76.11
- +57 ;;^UTILITY(U,$J,358.3,17467,2)
- +58 ;;=^5019570
- +59 ;;^UTILITY(U,$J,358.3,17468,0)
- +60 ;;=R79.1^^61^787^3
- +61 ;;^UTILITY(U,$J,358.3,17468,1,0)
- +62 ;;=^358.31IA^4^2
- +63 ;;^UTILITY(U,$J,358.3,17468,1,3,0)
- +64 ;;=3^Abnormal Coagulation Profile
- +65 ;;^UTILITY(U,$J,358.3,17468,1,4,0)
- +66 ;;=4^R79.1
- +67 ;;^UTILITY(U,$J,358.3,17468,2)
- +68 ;;=^5019591
- +69 ;;^UTILITY(U,$J,358.3,17469,0)
- +70 ;;=R82.5^^61^787^73
- +71 ;;^UTILITY(U,$J,358.3,17469,1,0)
- +72 ;;=^358.31IA^4^2
- +73 ;;^UTILITY(U,$J,358.3,17469,1,3,0)
- +74 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
- +75 ;;^UTILITY(U,$J,358.3,17469,1,4,0)
- +76 ;;=4^R82.5
- +77 ;;^UTILITY(U,$J,358.3,17469,2)
- +78 ;;=^5019605
- +79 ;;^UTILITY(U,$J,358.3,17470,0)
- +80 ;;=R82.6^^61^787^29
- +81 ;;^UTILITY(U,$J,358.3,17470,1,0)
- +82 ;;=^358.31IA^4^2
- +83 ;;^UTILITY(U,$J,358.3,17470,1,3,0)
- +84 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
- +85 ;;^UTILITY(U,$J,358.3,17470,1,4,0)
- +86 ;;=4^R82.6
- +87 ;;^UTILITY(U,$J,358.3,17470,2)
- +88 ;;=^5019606
- +89 ;;^UTILITY(U,$J,358.3,17471,0)
- +90 ;;=R82.90^^61^787^28
- +91 ;;^UTILITY(U,$J,358.3,17471,1,0)
- +92 ;;=^358.31IA^4^2
- +93 ;;^UTILITY(U,$J,358.3,17471,1,3,0)
- +94 ;;=3^Abnormal Urine Findings,Unspec
- +95 ;;^UTILITY(U,$J,358.3,17471,1,4,0)
- +96 ;;=4^R82.90
- +97 ;;^UTILITY(U,$J,358.3,17471,2)
- +98 ;;=^5019609
- +99 ;;^UTILITY(U,$J,358.3,17472,0)
- +100 ;;=R82.91^^61^787^52
- +101 ;;^UTILITY(U,$J,358.3,17472,1,0)
- +102 ;;=^358.31IA^4^2
- +103 ;;^UTILITY(U,$J,358.3,17472,1,3,0)
- +104 ;;=3^Chromoabnormalities of Urine NEC
- +105 ;;^UTILITY(U,$J,358.3,17472,1,4,0)
- +106 ;;=4^R82.91
- +107 ;;^UTILITY(U,$J,358.3,17472,2)
- +108 ;;=^5019610
- +109 ;;^UTILITY(U,$J,358.3,17473,0)
- +110 ;;=R89.9^^61^787^22
- +111 ;;^UTILITY(U,$J,358.3,17473,1,0)
- +112 ;;=^358.31IA^4^2
- +113 ;;^UTILITY(U,$J,358.3,17473,1,3,0)
- +114 ;;=3^Abnormal Organ/Tissue Specimen Findings,Unspec
- +115 ;;^UTILITY(U,$J,358.3,17473,1,4,0)
- +116 ;;=4^R89.9
- +117 ;;^UTILITY(U,$J,358.3,17473,2)
- +118 ;;=^5019702
- +119 ;;^UTILITY(U,$J,358.3,17474,0)
- +120 ;;=R90.0^^61^787^102
- +121 ;;^UTILITY(U,$J,358.3,17474,1,0)
- +122 ;;=^358.31IA^4^2
- +123 ;;^UTILITY(U,$J,358.3,17474,1,3,0)
- +124 ;;=3^Intracranial Space-Occupying Lesion Dx Imaging of Central Nervous System